Bosh sahifaRADL3 • BVMF
add
Raia Drogasil S/A
Yopilish kursi
25,37 R$
Kunlik diapazon
25,25 R$ - 26,10 R$
Yillik diapazon
23,83 R$ - 30,40 R$
Bozor kapitalizatsiyasi
44,70 mlrd BRL
Oʻrtacha hajm
6,46 mln
Narx/foyda
38,99
Dividend daromadliligi
0,96%
Asosiy maydon
BVMF
Bozor yangiliklari
MarketWatch
1 kun oldin
S&P 500 is on a 12-month tear as tariffs threaten 2025 outlook for U.S.
stocks
1,12%
0,35%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (BRL) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 9,99 mlrd | 15,14% |
Joriy xarajat | 2,36 mlrd | 14,71% |
Sof foyda | 335,02 mln | 27,05% |
Sof foyda marjasi | 3,35 | 10,20% |
Har bir ulushga tushum | 0,20 | 41,38% |
EBITDA | 790,34 mln | 13,05% |
Amaldagi soliq stavkasi | 23,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (BRL) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 410,51 mln | -33,74% |
Jami aktivlari | 21,96 mlrd | 13,25% |
Jami passivlari | 15,64 mlrd | 15,07% |
Umumiy kapital | 6,32 mlrd | — |
Tarqatilgan aksiyalar | 1,72 mlrd | — |
Narxi/balansdagi bahosi | 6,91 | — |
Aktivlardan daromad | 7,19% | — |
Kapitaldan daromad | 11,09% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (BRL) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 335,02 mln | 27,05% |
Operatsiyalardan naqd pul | 777,10 mln | 774,19% |
Sarmoyadan naqd pul | -369,18 mln | -5,41% |
Moliyadan naqd pul | -367,06 mln | -172,03% |
Naqd pulning sof oʻzgarishi | 40,85 mln | -83,55% |
Boʻsh pul | 628,44 mln | 586,27% |
Haqida
RD Saúde is the largest drugstore company in Latin America by revenue and market capitalization. With its headquarters in São Paulo, it has more than 3,000 pharmacies in Brazil with a national presence in all 27 states.
The company's pharmacies are branded as Raia and Drogasil and are supplied by 14 distribution centers. The company also leads in online audience through its proprietary Raia and Drogasil mobile apps and websites, which accounted for 15.2% of 2023 retail gross revenues according to publicly filed financial statements.
In an industry with 92 thousand pharmacies, the company's 3 thousand locations recorded a 15.5% market share in 2023.
RD Saúde's top 3 competitors include Grupo DPSP, Pague Menos and Farmácias São João. Wikipedia
Tashkil etilgan
10-noy, 2011
Sayt
Xodimlar soni
62 402
